← Open Payments lookup

HANH NGUYEN: Open Payments

NPI 1003454653 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,849 in 77 payments from 11 companies in 2025. Trend: 2023 $2,393 · 2024 $1,496 · 2025 $1,849

Food & beverage: $1,849
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$688
Otsuka America Pharmaceutical, Inc.11$258
LivaNova USA, Inc.4$209
ABBVIE INC.14$162
Neurocrine BioSciences, Inc.5$132
Janssen Pharmaceuticals, Inc5$131
E.R. Squibb & Sons, L.L.C.3$82
Takeda Pharmaceuticals U.S.A., Inc.2$51
Teva Pharmaceuticals USA, Inc.2$47
Lundbeck LLC2$47

Products named: CAPLYTA, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, REXULTI, VRAYLAR, INGREZZA, SPRAVATO, ABILIFY ASIMTUFII, COBENFY.

Industry payments across TX — which companies pay providers there.